$20.90
0.211.01%
Pre-Market: 7:03 AM EDT
Comments
Loading...
Summit Therapeutics Stock Guidance | NASDAQ:SMMT | Benzinga
Summit Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summit Therapeutics Inc (SMMT) does not provide guidance data | ||||||||||||
FAQ
What is the most recent guidance for Summit Therapeutics (SMMT)?
There have been no specific sales or earnings guidance reported for Summit Therapeutics in recent months.
Browse guidance and forecast on all stocks.